Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

n Share (unaudited)
(Amounts in Millions, except per share figures)

Twelve months ended December 31, 2006

Purchase Acquisition- Other

As Accounting Related Specified As

Reported Adjustments Items Items Reconciled

Net sales $ 10,594 $ - $ - $ - $10,594

Cost of sales 3,697 - - (146)

3,551

Selling, general

and administrative 4,718 - - - 4,718

Research and

development 2,188 - - (15) 2,173

Acquired in-process

research and

development - - - - -

Other income, net (135) - - - (135)

Special and

acquisition

related charges 102 - - (102) -

Equity income (1,459) - - - (1,459)

Income before

income taxes 1,483 - - 263 1,746

Income tax expense 362 - - - 362

Net income before

cumulative effect

of a change in

accounting

principle $1,121 $ - $ - $263 $ 1,384

Cumulative effect

of a change in

accounting principle,

net of tax (22) - - 22 -

Net income $1,143 $ - $ - $241 $ 1,384

Preferred stock

dividends 86 - - - 86

Net income available

to common

shareholders $1,057 $ - $ - $241 $1,298

Diluted earnings<
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , , MONTREAL, Nov. 19 /PRNewswire/ - Aege... the first patient in a randomized Phase 2B study ...id-stage development for multiple oncology indicat...domized Phase 2 Study of the X-Linked Inhibitor of...ination with High-dose Cytarabine and Idarubicin i...
(Date:11/19/2009)... , InSound is honored by ... Newark, CA (PRWEB) November 1...Lyric “invisible” hearing aid from InS...rsquo;s New Award in the Health category. &nb...Lyric is designed to reside deep in the hearing ca...
(Date:11/18/2009)... , A chemist at the National Institute of Standar...vely simple, inexpensive method for detecting and ...ives and toxins, invisible spoilage in food or pes...prototype method is more sensitive than convention...als, which are polarlike water molecules, having d...
(Date:11/18/2009)... , Scientists at Queen,s University Belfast are d...d illegal drugs which will help in the fight again...s will use special gel pads to ,swipe, an individu... analysed by a scanning instrument that can detect...ll allow better, faster decisions to be made in re...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric &#8220;Invisible&#8221; Hearing Aid 2009 &#8220;Best of What's New&#8221; Award 2Popular Science Awards Lyric &#8220;Invisible&#8221; Hearing Aid 2009 &#8220;Best of What's New&#8221; Award 3Prototype NIST method detects and measures elusive hazards 2New technology detects chemical weapons in seconds 2
... realize the electrical units of voltage, resistan...ts in nano-circuits are nowadays used. Important p...rs where high-mobile electrons move through the cr...To be prepared for future developments in quantum ...axy system optimized for the fabrication of highes...
...dy detailing effects of treatment of HIV-positive ... 10 treatment indicates significant improvement i...in-vitro laboratory work shows that ABL nanosilver...s, "eventually destroying the virus" ALPINE, UT, ...Labs,developer of a new class of products based on...
...29 Dendreon Corporation,(Nasdaq: DNDN ) today an...er,of Dendreon, will present a company update at t...n New York City, on Thursday, September 4, 2008 at...ntation will be accessible through the,Investor Re...w.dendreon.com . If you are unable to listen to th...
Other Biology Technology:'Racetrack' for fast electrons in semiconductor structures 2Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes 2
(Date:11/22/2009)...artnership of the University of British Columbia F...search Institute, have uncovered new information a...ing a stroke, as well as a possible way to mitigat...tly published online in Nature Medicine . , Fol...even after blood flow has been restored. Researche...
(Date:11/20/2009)...lipoprotein concentrations determined by nuclear m...led by Daniel Chasman at Brigham and Women,s Hospi...Framingham Heart Study in Framingham, and the PROC...England performed genetic association analysis acr...n ancestry from the Women,s Genome Health Study. T...
(Date:11/20/2009)... estimated 4.6 million Americans involved in the e...atory symptoms due to poor air quality in horse ba... earlier this year by investigators at Tufts Unive... The studywhich polled more than 80 New England h...als working in barns complained of coughing, wheez...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Evolution 3A Crabs go deep to avoid hot water 9101 1Evolution 3A Crabs go deep to avoid hot water 9101 2Virus resistant grapevines 9098 1Virus resistant grapevines 9098 2Health Care Reform and Chronic Disease 50654 1Health Care Reform and Chronic Disease 50654 2Health Care Reform and Chronic Disease 50654 3Health Care Reform and Chronic Disease 50654 4
...in German . , Together with colleagues from the ...er for Allergy and Environment of the Technische U...rum Mnchen have pinpointed a major gene for allerg...edge technologies for examining the whole human ge...discovered FCER1A gene encodes the alpha chain of ...
...ity and the University of St. Andrews, United King...eces of information may or may not easily cause a ...ed information. The key, they find, is in the way...etails are published August 22nd in the open-acces...e learns a language and then doesn,t use it, one m...
... Energy Secretary Samuel Bodman and Enrique Santac...ynote speakers during GridWeek 2008 in Washington....an Building and International Trade Center, is an ...ought leaders. IEEE-USA is a major partner of Grid...heir addresses on Wednesday 24 September from 8:30...
Other Biology News:Munich researchers discover key allergy gene 2Energy secretary, IEEE-member industry leader to deliver keynote addresses during GridWeek 2008 2
... Activation of ICE-family proteases/caspases initi... Flow Cytometric Apoptosis Detection Kit provides ...tion of caspases by flow cytometry in intact cells...o aspartate residues linked to rhodamine 110 (D2R)...
... pLivSelect is a direct antibiotic-based selection...t selection depends solely on colony survival, eli... quick and inexpensive process provides close to 1...is also the ideal platform for robot colony pickin...
... Nikon's NIS-Elements revolutionizes imaging s...omated intelligence to microscopes, cameras, compo...lysis, visualization and achiving tools. Its intui...mage acquisition times while providing powerful fe...
BD BioCoat Vented Caps for 175 cm2 Flasks from BD Biosciences - Discovery Labware
Biology Products: